Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology announces approval to commercialise Tobramycin eye drops in China

June 13 (Reuters) - Essex Bio-technology Ltd  1061.HK  : 
    * Announces approval to commercialise preservative-free 
single-dose Tobramycin eye drops in China 
    * Approved product is expected to be launched in market at 
or around end of 2017 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nHKSblP8w2 
Further company coverage:  1061.HK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news